MARVIN SAMSON Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MARVIN SAMSON.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MARVIN SAMSON. MARVIN SAMSON is Chief Executive Officer in SICOR INC ($SCRI) and Director in ANTARES PHARMA, INC. ($ATRS).
Latest Insider Trading Transactions of MARVIN SAMSON
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 14 2020 | ATRS | ANTARES PHARMA, IN ... | SAMSON MARVIN | Director | Option Exercise | M | 2.66 | 56 | 149 | 0 | |
| Jan 14 2020 | ATRS | ANTARES PHARMA, IN ... | SAMSON MARVIN | Director | Sell | S | 4.50 | 56 | 252 | 51,751 | 51.8 K to 51.8 K (-0.11 %) |
| Jan 14 2020 | ATRS | ANTARES PHARMA, IN ... | SAMSON MARVIN | Director | Buy | M | 2.66 | 56 | 149 | 51,807 | 51.8 K to 51.8 K (+0.11 %) |
| Jan 06 2020 | ATRS | ANTARES PHARMA, IN ... | SAMSON MARVIN | Director | Option Exercise | M | 2.66 | 549 | 1,460 | 0 | |
| Jan 06 2020 | ATRS | ANTARES PHARMA, IN ... | SAMSON MARVIN | Director | Option Exercise | M | 2.18 | 99,395 | 216,681 | 0 | |
| Jan 06 2020 | ATRS | ANTARES PHARMA, IN ... | SAMSON MARVIN | Director | Sell | S | 4.60 | 549 | 2,525 | 51,751 | 52.3 K to 51.8 K (-1.05 %) |
| Jan 06 2020 | ATRS | ANTARES PHARMA, IN ... | SAMSON MARVIN | Director | Buy | M | 2.66 | 549 | 1,460 | 52,300 | 51.8 K to 52.3 K (+1.06 %) |
| Jan 06 2020 | ATRS | ANTARES PHARMA, IN ... | SAMSON MARVIN | Director | Sell | S | 4.60 | 49,395 | 227,217 | 51,751 | 101.1 K to 51.8 K (-48.84 %) |
| Jan 06 2020 | ATRS | ANTARES PHARMA, IN ... | SAMSON MARVIN | Director | Buy | M | 2.18 | 49,395 | 107,681 | 101,146 | 51.8 K to 101.1 K (+95.45 %) |
| Jan 06 2020 | ATRS | ANTARES PHARMA, IN ... | SAMSON MARVIN | Director | Sell | S | 4.59 | 50,000 | 229,500 | 51,751 | 101.8 K to 51.8 K (-49.14 %) |
| Jan 06 2020 | ATRS | ANTARES PHARMA, IN ... | SAMSON MARVIN | Director | Buy | M | 2.18 | 50,000 | 109,000 | 101,751 | 51.8 K to 101.8 K (+96.62 %) |
| Dec 26 2019 | ATRS | ANTARES PHARMA, IN ... | SAMSON MARVIN | Director | Option Exercise | M | 1.12 | 150,000 | 168,000 | 0 | |
| Dec 26 2019 | ATRS | ANTARES PHARMA, IN ... | SAMSON MARVIN | Director | Sell | S | 4.71 | 150,000 | 706,500 | 51,751 | 201.8 K to 51.8 K (-74.35 %) |
| Dec 26 2019 | ATRS | ANTARES PHARMA, IN ... | SAMSON MARVIN | Director | Buy | M | 1.12 | 150,000 | 168,000 | 201,751 | 51.8 K to 201.8 K (+289.85 %) |
| Nov 13 2019 | ATRS | ANTARES PHARMA, IN ... | SAMSON MARVIN | Director | Gift | G | 3.77 | 25,000 | 94,250 | 51,751 | 76.8 K to 51.8 K (-32.57 %) |
| Jun 14 2019 | ATRS | ANTARES PHARMA, IN ... | SAMSON MARVIN | Director | Option Exercise | A | 2.92 | 46,729 | 136,449 | 46,729 | |
| Jun 14 2019 | ATRS | ANTARES PHARMA, IN ... | SAMSON MARVIN | Director | Grant | A | 2.92 | 23,973 | 70,001 | 76,751 | 52.8 K to 76.8 K (+45.42 %) |
| Jun 11 2018 | ATRS | ANTARES PHARMA, IN ... | SAMSON MARVIN | Director | Option Exercise | A | 2.70 | 76,548 | 206,680 | 76,548 | |
| Jun 09 2017 | ATRS | ANTARES PHARMA, IN ... | SAMSON MARVIN | Director | Option Exercise | A | 2.66 | 80,318 | 213,646 | 80,318 | |
| Apr 12 2017 | ATRS | ANTARES PHARMA, IN ... | SAMSON MARVIN | Director | Gift | G | 2.80 | 50,000 | 140,000 | 52,778 | 102.8 K to 52.8 K (-48.65 %) |
| Jun 06 2016 | ATRS | ANTARES PHARMA, IN ... | SAMSON MARVIN | Director | Option Exercise | A | 1.12 | 150,000 | 168,000 | 150,000 | |
| Mar 21 2016 | ATRS | ANTARES PHARMA, IN ... | SAMSON MARVIN | Director | Buy | P | 0.72 | 50,000 | 36,000 | 102,778 | 52.8 K to 102.8 K (+94.74 %) |
| Jun 01 2015 | ATRS | ANTARES PHARMA, IN ... | SAMSON MARVIN | Director | Option Exercise | A | 2.18 | 99,395 | 216,681 | 99,395 | |
| Jan 22 2004 | SCRI | SICOR INC | SAMSON MARVIN | Chief Executive Off ... | Option Exercise | M | 15.19 | 25,000 | 379,750 | 0 | |
| Jan 22 2004 | SCRI | SICOR INC | SAMSON MARVIN | Chief Executive Off ... | Option Exercise | M | 10.12 | 250,000 | 2,530,000 | 0 | |
| Jan 22 2004 | SCRI | SICOR INC | SAMSON MARVIN | Chief Executive Off ... | Option Exercise | M | 15.75 | 1,000,000 | 15,750,000 | 0 | |
| Jan 22 2004 | SCRI | SICOR INC | SAMSON MARVIN | Chief Executive Off ... | Sell | S | 27.66 | 25,000 | 691,375 | 0 | 25 K to 0 (-100.00 %) |
| Jan 22 2004 | SCRI | SICOR INC | SAMSON MARVIN | Chief Executive Off ... | Buy | M | 15.19 | 25,000 | 379,750 | 0 | -25,000 to 0 (-100.00 %) |
| Jan 22 2004 | SCRI | SICOR INC | SAMSON MARVIN | Chief Executive Off ... | Sell | S | 27.66 | 250,000 | 6,913,750 | 0 | 250 K to 0 (-100.00 %) |
| Jan 22 2004 | SCRI | SICOR INC | SAMSON MARVIN | Chief Executive Off ... | Buy | M | 10.12 | 250,000 | 2,530,000 | 0 | -250,000 to 0 (-100.00 %) |
| Jan 22 2004 | SCRI | SICOR INC | SAMSON MARVIN | Chief Executive Off ... | Sell | S | 27.66 | 1,000,000 | 27,655,000 | 0 | 1000 K to 0 (-100.00 %) |
| Jan 22 2004 | SCRI | SICOR INC | SAMSON MARVIN | Chief Executive Off ... | Buy | M | 15.75 | 1,000,000 | 15,750,000 | 0 | -1,000,000 to 0 (-100.00 %) |
| Jan 16 2004 | SCRI | SICOR INC | SAMSON MARVIN | Chief Executive Off ... | Option Exercise | A | 27.60 | 35,000 | 966,000 | 0 |
Page: 1